About Dravya

Clarity Starts Here

Dravya Discovery is a UK-based preclinical, translational CRO specialising in ophthalmology research services. We partner with biotech, pharma and academic teams to generate human-relevant, decision-driving data that accelerates the translation of ophthalmic innovations from discovery to the clinic.
Our expertise spans in vitro and ex vivo ophthalmic models, biomarker discovery, mechanism-of-action studies and efficacy testing across retinal, corneal and ocular surface indications. By combining scientific rigour with flexible, milestone-driven project design, we help clients de-risk development, optimise R&D spend and move confidently toward clinical milestones.
Backed by the capabilities and quality systems of Cellomatics Biosciences, Dravya Discovery delivers responsive, high-quality research support tailored to the needs of early-stage and growing ophthalmology programmes.

Partner with Dravya

Home Page Book an appointment
Research

Research Focus Areas

Comprehensive investigation across the key vision system

Glaucoma
Retinal Degenerative Diseases
Age-Related Macular Degeneration (AMD)
Retinal and Ocular Angiogenesis
Our Vision

Vision for the Future

Our Vision is a future where innovative eye therapies reach patients faster, enabled by scientific rigour, collaboration, and translational excellence. 

  • Fast-tracking new eye treatments.
  • Reliable, evidence-based research.
  • Turning science into patient impact.
Our Mission

Mission That Drives Us

Our mission at Dravya Discovery is to transform ophthalmology research through innovation, predictive translational models, helping collaborators de-risk development and bring effective eye therapies to the clinic faster.

  • Driving breakthroughs in ophthalmology.
  • Using translational science to de-risk development.
  • Bringing effective eye therapies to the clinic sooner.
OUR BLOGS

Insights for Clearer Vision

The Growing Opportunity in Ophthalmology Therapeutics
MARCH 7, 2026
The Growing Opportunity in Ophthalmology Therapeutics
READ MORE ⓘ
How CRO Partnerships Accelerate Ophthalmology Innovation
MARCH 7, 2026
How CRO Partnerships Accelerate Ophthalmology Innovation
READ MORE ⓘ
Why We Founded Dravya Discovery – Building the Future of Ophthalmology Drug Discovery
MARCH 7, 2026
Why We Founded Dravya Discovery – Building the Future of Ophthalmology Drug Discovery
READ MORE ⓘ
collboarate with dravya

Let's advance eye research together.

Subscribe to our newsletter and stay updated with latest research and publishes.

Subscription Form